{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:29:39Z","timestamp":1774261779140,"version":"3.50.1"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1002610","type":"journal-article","created":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T01:52:58Z","timestamp":1343353978000},"page":"e1002610","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":47,"title":["Modeling of Pharmacokinetics of Cocaine in Human Reveals the Feasibility for Development of Enzyme Therapies for Drugs of Abuse"],"prefix":"10.1371","volume":"8","author":[{"given":"Fang","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Guo","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"ref1","article-title":"World Drug Report 2010. Report June 2010-1,700","year":"2010"},{"key":"ref2","article-title":"Understanding Drug Abuse and Addiction. Report March 2011","year":"2011"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1749-6632.2009.05148.x","article-title":"Regulation of the dopamine transporter: Aspects relevant to psychostimulant drugs of abuse.","volume":"1187","author":"KC Schmitt","year":"2010","journal-title":"Ann NY Acad Sci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1586\/17512433.1.2.277","article-title":"Pharmacokinetic approaches to treatment of drug addiction.","volume":"1","author":"DA Gorelick","year":"2008","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pbb.2009.01.015","article-title":"Immunopharmacotherapy: Vaccination strategies as a treatment for drug abuse and dependence.","volume":"92","author":"AY Moreno","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1529\/biophysj.107.110924","article-title":"How dopamine transporter interacts with dopamine: insights from molecular modeling and simulation.","volume":"93","author":"X Huang","year":"2007","journal-title":"Biophys J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nn.2146","article-title":"The binding sites for cocaine and dopamine in the dopamine transporter overlap.","volume":"11","author":"T Beuming","year":"2008","journal-title":"Nat Neurosci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"15057","DOI":"10.1021\/jp900963n","article-title":"Mechanism for cocaine blocking the transport of dopamine: Insights from molecular modeling and dynamics simulations.","volume":"113","author":"X Huang","year":"2009","journal-title":"J Phys Chem B"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4155\/fmc.10.275","article-title":"Enzyme-therapy approaches for the treatment of drug overdose and addiction.","volume":"3","author":"F Zheng","year":"2011","journal-title":"Future Med Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0376-8716(97)00119-1","article-title":"Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy.","volume":"48","author":"DA Gorelick","year":"1997","journal-title":"Drug Alcohol Depend"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1126\/science.8456315","article-title":"Antibody-Catalyzed Degradation of Cocaine.","volume":"259","author":"DW Landry","year":"1993","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJM199604113341507","article-title":"Drug therapy: Management of cocaine abuse and dependence.","volume":"334","author":"JH Mendelson","year":"1996","journal-title":"New England J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00213-009-1655-8","article-title":"Cocaine craving and use during daily life.","volume":"207","author":"KL Preston","year":"2009","journal-title":"Psychopharmacology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/jcc.20241","article-title":"First-principle studies of intermolecular and intramolecular catalysis of protonated cocaine.","volume":"26","author":"CG Zhan","year":"2005","journal-title":"J Comput Chem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1021\/ja043935e","article-title":"Fluorescent cocaine probes: A tool for the selection and engineering of therapeutic antibodies.","volume":"127","author":"MM Meijler","year":"2005","journal-title":"J Am Chem Soc"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1128\/AEM.66.3.904-908.2000","article-title":"Gene cloning and nucleotide sequencing and properties of a cocaine esterase from Rhodococcus sp strain MB1.","volume":"66","author":"MM Bresler","year":"2000","journal-title":"Appl Env Microbiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nsb742","article-title":"Crystal structure of a bacterial cocaine esterase.","volume":"9","author":"NA Larsen","year":"2002","journal-title":"Nature Struct Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"12297","DOI":"10.1021\/bi026131p","article-title":"Biochemical characterization and structural analysis of a highly proficient cocaine esterase.","volume":"41","author":"JM Turner","year":"2002","journal-title":"Biochemistry"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0022-1759(02)00237-5","article-title":"Anticocaine catalytic antibodies.","volume":"269","author":"SX Deng","year":"2002","journal-title":"J Immunol Methods"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1124\/mol.55.1.83","article-title":"An improved cocaine hydrolase: The A328Y mutant of human butyrylcholinesterase is 4-fold more efficient.","volume":"55","author":"WH Xie","year":"1999","journal-title":"Mol Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/mol.62.2.220","article-title":"Re-engineering butyrylcholinesterase as a cocaine hydrolase.","volume":"62","author":"H Sun","year":"2002","journal-title":"Mol Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1021\/jp0447136","article-title":"Molecular dynamics simulation of cocaine binding with human butyrylcholinesterase and its mutants.","volume":"109","author":"A Hamza","year":"2005","journal-title":"J Phys Chem B"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1529\/biophysj.105.070276","article-title":"Catalytic mechanism and energy barriers for butyrylcholinesterase-catalyzed hydrolysis of cocaine.","volume":"89","author":"CG Zhan","year":"2005","journal-title":"Biophys J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/mol.108.049486","article-title":"Thermostable Variants of Cocaine Esterase for Long-Time Protection against Cocaine Toxicity.","volume":"75","author":"DQ Gao","year":"2009","journal-title":"Mol Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/17512433.2.1.1","article-title":"Novel pharmacological approaches to treatment of drug overdose and addiction.","volume":"2","author":"CG Zhan","year":"2009","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4155\/fmc.09.20","article-title":"Recent progress in protein drug design and discovery with a focus on novel approaches to the development of anticocaine medications.","volume":"1","author":"F Zheng","year":"2009","journal-title":"Future Med Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1039\/B716268E","article-title":"Structure-and-mechanism-based design and discovery of therapeutics for cocaine overdose and addiction.","volume":"6","author":"F Zheng","year":"2008","journal-title":"Org Biomole Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"16656","DOI":"10.1073\/pnas.0507332102","article-title":"Computational redesign of human butyrylcholinesterase for anticocaine medication.","volume":"102","author":"YM Pan","year":"2005","journal-title":"Proc Nat Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cbi.2010.01.004","article-title":"Characterization of a high-activity mutant of human butyrylcholinesterase against (\u2212)-cocaine.","volume":"187","author":"W Yang","year":"2010","journal-title":"Chem Biol Interact"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"12148","DOI":"10.1021\/ja803646t","article-title":"Most efficient cocaine hydrolase designed by virtual screening of transition states.","volume":"130","author":"F Zheng","year":"2008","journal-title":"J Am Chem Soc"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/j.bpj.2008.11.051","article-title":"Free-Energy Perturbation Simulation on Transition States and Redesign of Butyrylcholinesterase.","volume":"96","author":"WC Yang","year":"2009","journal-title":"Biophys J"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1124\/mol.110.068494","article-title":"Design, Preparation, and Characterization of High-Activity Mutants of Human Butyrylcholinesterase Specific for Detoxification of Cocaine.","volume":"79","author":"L Xue","year":"2011","journal-title":"Mol Pharmacol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1124\/mol.109.060806","article-title":"A Thermally Stable Form of Bacterial Cocaine Esterase: A Potential Therapeutic Agent for Treatment of Cocaine Abuse.","volume":"77","author":"RL Brim","year":"2010","journal-title":"Mol Pharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1124\/jpet.108.150029","article-title":"Cocaine Esterase Prevents Cocaine-Induced Toxicity and the Ongoing Intravenous Self-Administration of Cocaine in Rats.","volume":"331","author":"GT Collins","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"9113","DOI":"10.1021\/bi1011628","article-title":"Design of high-activity mutants of human butyrylcholinesterase against (\u2212)-cocaine: structural and energetic factors affecting the catalytic efficiency.","volume":"49","author":"F Zheng","year":"2010","journal-title":"Biochemistry"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1038\/sj.npp.1301666","article-title":"A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats.","volume":"33","author":"S Brimijoin","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/syn.890040412","article-title":"Mapping cocaine binding sites in human and baboon brain in vivo.","volume":"4","author":"JS Fowler","year":"1989","journal-title":"Synapse"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0006-2952(91)90665-R","article-title":"Activities of the Enantiomers of Cocaine and Some Related-Compounds as Substrates and Inhibitors of Plasma Butyrylcholinesterase.","volume":"41","author":"SJ Gatley","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"ref39","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-61823-9","article-title":"Identifiability of State Space Models","author":"E Walter","year":"1982"},{"key":"ref40","article-title":"Pharmacokinetic-Pharmacodynamic Modeling and Simulation","author":"PL Bonate","year":"2006"},{"key":"ref41","article-title":"Introduction to Modeling in Physiology and Medicine","author":"C Cobelli","year":"2008"},{"key":"ref42","first-page":"48","article-title":"Pharmacokinetic studies of cocaine and phencyclidine in man.","author":"CE Cook","year":"1985"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.2967\/jnumed.107.040279","article-title":"PET studies of d-methamphetamine pharmacokinetics in primates: comparison with l-methamphetamine and (\u2212)-cocaine.","volume":"48","author":"JS Fowler","year":"2007","journal-title":"J Nucl Med"},{"key":"ref44","article-title":"ADAPT II User's Guide: Pharmacokinetic\/Pharmacodynamic Systems Analysis Software","author":"DZ D'Argenio","year":"1997"},{"key":"ref45","article-title":"Computational modeling of the EGF receptor signaling network [M.Sc. Thesis]","author":"F Zheng","year":"2004"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.parco.2004.08.001","article-title":"Large-scale simulations of cellular signaling processes.","volume":"30","author":"JH Miller","year":"2004","journal-title":"Parallel Comput"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1667\/RR3321","article-title":"A Model of Cytokine Shedding Induced by Low Doses of Gamma Radiation.","volume":"163","author":"JH Miller","year":"2005","journal-title":"Radiat Res"},{"key":"ref48","first-page":"1","article-title":"Large-Scale Purification of Butyrylcholinesterase from Human Plasma Suitable for Injection into Monkeys; a Potential New Therapeutic for Protection against Cocaine and Nerve Agent Toxicity.","volume":"3","author":"O Lockridge","year":"2005","journal-title":"J Med Chem Biol Radiol Defense"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1107\/S1744309107037335","article-title":"Crystallization and X-ray structure of full-length recombinant human butyrylcholinesterase.","volume":"63","author":"MN Ngamelue","year":"2007","journal-title":"Acta Crystallogr F-Struct Biol Cryst Commun"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.1021\/jp8114995","article-title":"Model of Human Butyrylcholinesterase Tetramer by Homology Modeling and Dynamics Simulation.","volume":"113","author":"YM Pan","year":"2009","journal-title":"J Phys Chem B"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.clinbiochem.2007.01.018","article-title":"Determination of butyrylcholinesterase (BChE) phenotypes to predict the risk of prolonged apnea in persons receiving succinylcholine in the healthy population of western Iran.","volume":"40","author":"A Vaisi-Raygani","year":"2007","journal-title":"Clin Biochem"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jneumeth.2008.08.027","article-title":"Striatal volume differences between non-human and human primates.","volume":"176","author":"D Yin","year":"2009","journal-title":"J Neurosci Methods"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1023\/A:1012121916369","article-title":"Cocaine pharmacokinetics\/pharmacodynamics in awake freely moving rats.","volume":"14","author":"M Hedaya","year":"1997","journal-title":"Pharm Res"},{"key":"ref54","first-page":"1","article-title":"An animal model for simultaneous pharmacokinetic\/pharmacodynamic investigations: application to cocaine.","volume":"39","author":"W Pan","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"10599","DOI":"10.1021\/jp072917r","article-title":"First-principles calculation of pKa for cocaine, nicotine, neurotransmitters, and anilines in aqueous solution.","volume":"111","author":"H-T Lu","year":"2007","journal-title":"J Phys Chem B"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1124\/jpet.109.152231","article-title":"Lasting Reduction of Cocaine Action in Neostriatum-A Hydrolase Gene Therapy Approach.","volume":"330","author":"Y Gao","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0378-8741(81)90063-5","article-title":"Cocaine Pharmacokinetics in Humans.","volume":"3","author":"G Barnett","year":"1981","journal-title":"J Ethnopharmacol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cbi.2010.02.036","article-title":"The concept of pharmacologic cocaine interception as a treatment for drug abuse.","volume":"187","author":"Y Gao","year":"2010","journal-title":"Chem Biol Interact"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/386827a0","article-title":"Relationship between subjective effects of cocaine and dopamine transporter occupancy.","volume":"386","author":"ND Volkow","year":"1997","journal-title":"Nature"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/jat\/22.6.435","article-title":"Cocaine and metabolite concentrations in plasma during repeated oral administration: Development of a human laboratory model of chronic cocaine use.","volume":"22","author":"RA Jufer","year":"1998","journal-title":"J Anal Toxicol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1074\/jbc.M006676200","article-title":"Predicted Michaelis-Menten complexes of cocaine-butyrylcholinesterase - Engineering effective butyrylcholinesterase mutants for cocaine detoxication.","volume":"276","author":"H Sun","year":"2001","journal-title":"J Biol Chem"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1471-4159.1990.tb01933.x","article-title":"Rapid stereoselective hydrolysis of (+)-cocaine in baboon plasma prevents its uptake in the brain: implications for behavioral studies.","volume":"54","author":"SJ Gatley","year":"1990","journal-title":"J Neurochem"}],"container-title":["PLoS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002610","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T19:24:58Z","timestamp":1562009098000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1002610"}},"subtitle":[],"editor":[{"given":"Michael","family":"Chappell","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,7,26]]},"references-count":62,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1002610","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,26]]}}}